Carcinogenicity of lipid-lowering drugs.
Cattley
R C
RC
D042962:Acyl-CoA Oxidase; D000818:Animals; D015248:Gemfibrozil / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D008113:Liver Neoplasms / Q000139:chemically induced*; D008830:Microbodies / Q000187:drug effects; D010088:Oxidoreductases / Q000187:drug effects; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects; D012377:Rodentia; D014157:Transcription Factors / Q000187:drug effects
D000960:Hypolipidemic Agents; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D010088:Oxidoreductases; D042962:Acyl-CoA Oxidase; D015248:Gemfibrozil